Sequential evaluation of the microbiome in patients with cervical cancer treated with chemoradiotherapy
Summary
This study will evaluate the microbiome (bacterial population) in both the tumour and the patient, to determine the numbers and types of bacteria present and to see whether this influences immune status and/or the patient's response to their treatment. We will be collecting stool, urine and blood before, during and after treatment, as well as testing the pre-treatment tumour.
Eligibility
Eligible gender: Female
Eligible ages: 18 to 80
Inclusion criteria:
1. Patients diagnosed with cervical cancer, for treatment with chemoradiotherapy.
2. Patients 18 years of age or older.
3. Able to give informed consent
Exclusion criteria:
1. Patients not fit to receive chemoradiotherapy for cervical cancer.
2. Patients younger than 18 years of age
3. Patients unable to give informed consent.
Participate
Additional information
Contact information
Physician referral only
Principal investigator:
Corinne Margaret Doll
Clinical trial:
No
REB-ID:
HREBA.CC-21-0265